Search results
Agios (AGIO) Q1 Earnings Beat Estimates, Revenues Up Y/Y
Zacks via Yahoo Finance· 12 months agoAgios Pharmaceuticals, Inc. AGIO reported a loss of $1.47 per share in first-quarter 2023, narrower...
Agios (AGIO) Q2 Loss Narrower Than Expected, Sales Beat
Zacks via Yahoo Finance· 2 years agoAgios Pharmaceuticals' (AGIO) posts encouraging results for the second quarter. The company is...
French drugmaker Servier ordered to pay $471 million for Mediator scandal
Reuters via AOL· 4 months agoDrugmaker Servier must pay more than 430 million euros ($471 million) in connection with weight-loss pill Mediator, a French court ruled on Wednesday, saying the company was guilty of fraud ...
Drug developer Servier's brain cancer drug slows tumor progession considerably
Reuters via Yahoo Finance· 11 months agoPrivate drug developer Servier Group said on Sunday its experimental brain cancer treatment has considerably slowed the progession of a type of brain tumor, a positive in a field that has not ...
Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) Q1 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 12 months agoPieris Pharmaceuticals, Inc. (NASDAQ:PIRS) Q1 2023 Earnings Call Transcript May 10, 2023 Operator:...
3 Penny Stocks That Could Make You Filthy Rich
Motley Fool· 1 year agoThe current economic environment, however, has pushed several intriguing, innovation-oriented companies into penny stock territory. Although these names...
Why Europe's drug shortages may get worse
Reuters via Yahoo News· 1 year agoWhen Ignasi Biosca-Reig heard there were shortages of amoxicillin in Spain, he quickly added shifts at his drug company's factories to boost production...
Q2 2023 Agios Pharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 9 months agoParticipants Brian M. Goff; CEO & Director; Agios Pharmaceuticals, Inc. Cecilia Jones; CFO; Agios Pharmaceuticals, Inc. Chris Taylor Sarah Gheuens; Chief Medical Officer and Head of Research ...
3 Penny Stocks to Make You the Millionaire Next Door
InvestorPlace via Yahoo Finance· 11 months agoWhen it comes to investing, penny stocks often evoke a sense of intrigue and opportunity. These low-priced securities, typically traded under $5 per...
3 Under-the-Radar Biotech Stocks to Buy in 2022
Motley Fool· 1 year agoBeam Therapeutics is different from many CRISPR-editing biotechs in that it uses ex-vivo base cell editing instead of nuclease cell editing. Beam stock...
